Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (434)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
64
2022
1965
4.100
 Why?
Receptor, ErbB-2
24
2018
320
2.920
 Why?
Metformin
10
2018
295
2.370
 Why?
Tamoxifen
10
2020
198
1.660
 Why?
Receptors, Estrogen
15
2020
387
1.560
 Why?
Receptor, ErbB-3
8
2016
42
1.440
 Why?
Cell Proliferation
15
2018
2275
1.260
 Why?
Genes, erbB-2
8
2013
27
1.220
 Why?
Mammary Neoplasms, Experimental
6
2017
63
1.170
 Why?
Apoptosis
20
2018
2484
0.850
 Why?
Cell Line, Tumor
22
2020
2851
0.800
 Why?
Thyroid Hormones
1
2020
55
0.750
 Why?
Hormone Replacement Therapy
1
2020
80
0.720
 Why?
Up-Regulation
3
2020
872
0.720
 Why?
Triple Negative Breast Neoplasms
3
2016
164
0.680
 Why?
Mammary Neoplasms, Animal
3
2018
29
0.670
 Why?
Disease-Free Survival
11
2020
649
0.640
 Why?
Immunohistochemistry
24
2017
1691
0.610
 Why?
Tumor Suppressor Protein p53
13
2011
455
0.600
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
60
0.580
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1167
0.580
 Why?
Biomarkers, Tumor
10
2021
1059
0.580
 Why?
ErbB Receptors
4
2010
569
0.580
 Why?
Testicular Neoplasms
3
2023
95
0.570
 Why?
Claudins
1
2016
24
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1390
0.540
 Why?
Antineoplastic Agents
9
2018
1974
0.540
 Why?
Receptor, IGF Type 1
3
2016
59
0.530
 Why?
Transcriptome
1
2020
756
0.510
 Why?
Hypoglycemic Agents
3
2017
1032
0.490
 Why?
Carcinogenesis
1
2016
182
0.490
 Why?
Prognosis
17
2016
3443
0.480
 Why?
Carcinoma, Ductal, Breast
5
2002
91
0.470
 Why?
Estradiol
2
2009
476
0.460
 Why?
Cell Cycle
4
2013
550
0.460
 Why?
Trastuzumab
7
2016
92
0.460
 Why?
Caspases
4
2009
269
0.450
 Why?
Genistein
2
2010
20
0.450
 Why?
Lymphatic Metastasis
16
2021
307
0.440
 Why?
Antineoplastic Agents, Hormonal
5
2020
143
0.420
 Why?
Receptors, Steroid
1
2012
54
0.410
 Why?
Female
64
2022
61565
0.410
 Why?
Antimetabolites, Antineoplastic
1
2012
83
0.400
 Why?
Drug Resistance, Neoplasm
9
2016
671
0.390
 Why?
Signal Transduction
15
2018
4709
0.390
 Why?
Neoplasm Invasiveness
7
2016
462
0.370
 Why?
STAT3 Transcription Factor
1
2012
189
0.370
 Why?
Genes, p53
5
2000
64
0.360
 Why?
Humans
81
2023
118974
0.340
 Why?
Neoplasm Proteins
5
2016
401
0.340
 Why?
Glucose
1
2013
953
0.320
 Why?
Glycoproteins
2
2005
319
0.320
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
404
0.320
 Why?
Mammary Tumor Virus, Mouse
2
2004
41
0.310
 Why?
Mice
17
2022
15520
0.300
 Why?
Mice, Transgenic
8
2018
2025
0.300
 Why?
MCF-7 Cells
4
2020
111
0.290
 Why?
MicroRNAs
4
2021
637
0.290
 Why?
Carcinoma
4
1995
204
0.280
 Why?
Doxorubicin
9
2011
302
0.270
 Why?
Bromodeoxyuridine
2
1999
76
0.270
 Why?
Protein Kinase Inhibitors
3
2016
811
0.270
 Why?
Polymerase Chain Reaction
6
2021
1012
0.260
 Why?
Xenograft Model Antitumor Assays
3
2020
740
0.250
 Why?
Antibodies, Monoclonal
6
2013
1284
0.250
 Why?
Tyrosine
2
2007
233
0.250
 Why?
Radiation Tolerance
1
2005
98
0.250
 Why?
Animals
22
2022
33381
0.250
 Why?
Quinazolines
2
2016
245
0.240
 Why?
Phosphorylation
5
2011
1633
0.230
 Why?
Cocarcinogenesis
1
2003
13
0.230
 Why?
Isoflavones
1
2003
24
0.230
 Why?
Paclitaxel
4
2015
195
0.230
 Why?
Cell Survival
5
2018
1047
0.230
 Why?
Seminoma
1
2023
17
0.230
 Why?
Chromosomes
1
2003
87
0.220
 Why?
Multivariate Analysis
7
2005
1474
0.220
 Why?
Receptors, Progesterone
5
2012
325
0.220
 Why?
Chromosomes, Human, Pair 8
1
2002
32
0.220
 Why?
Cyclins
2
2000
82
0.210
 Why?
Chromosome Aberrations
1
2002
136
0.210
 Why?
Enzyme Activation
3
2009
828
0.200
 Why?
Cyclophosphamide
7
2011
222
0.200
 Why?
Ki-67 Antigen
3
2014
108
0.200
 Why?
Orchiectomy
1
2021
57
0.200
 Why?
Breast
4
2018
140
0.200
 Why?
Retroperitoneal Neoplasms
1
2021
23
0.200
 Why?
Diet
3
2018
1153
0.190
 Why?
Obesity
4
2022
2746
0.190
 Why?
Rats
7
2022
5392
0.190
 Why?
Survival Analysis
7
2005
1267
0.190
 Why?
Neoplasm Staging
8
2021
1223
0.190
 Why?
Neoplastic Stem Cells
2
2014
336
0.190
 Why?
Teratoma
1
2021
92
0.180
 Why?
TOR Serine-Threonine Kinases
3
2012
369
0.180
 Why?
Phosphatidylinositol 3-Kinases
3
2011
341
0.180
 Why?
Middle Aged
26
2021
27617
0.180
 Why?
Mice, SCID
1
2020
333
0.180
 Why?
Ovarian Neoplasms
4
1995
420
0.180
 Why?
Carcinoma, Papillary
1
1999
76
0.170
 Why?
Proto-Oncogene Proteins
5
2008
618
0.170
 Why?
Mitotic Index
1
1999
27
0.170
 Why?
Antigens, Neoplasm
2
2009
228
0.170
 Why?
Mice, Inbred NOD
1
2020
574
0.170
 Why?
Receptors, Androgen
2
2017
134
0.170
 Why?
Chemotherapy, Adjuvant
5
2015
360
0.170
 Why?
Aromatase
1
2018
31
0.160
 Why?
Autism Spectrum Disorder
1
2023
323
0.160
 Why?
Drug Synergism
3
2018
339
0.160
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.160
 Why?
Kaplan-Meier Estimate
1
2020
842
0.160
 Why?
HSP90 Heat-Shock Proteins
1
2018
45
0.160
 Why?
Phenylthiohydantoin
2
2017
40
0.160
 Why?
Ovariectomy
4
2022
124
0.150
 Why?
Fluorouracil
5
2009
151
0.150
 Why?
Tumor Burden
4
2022
274
0.150
 Why?
In Situ Hybridization, Fluorescence
4
2008
310
0.150
 Why?
Down-Regulation
3
2010
627
0.150
 Why?
Poly(ADP-ribose) Polymerases
2
2009
87
0.150
 Why?
Postmenopause
5
2022
305
0.150
 Why?
Organic Cation Transport Proteins
1
2017
28
0.150
 Why?
Cell Division
4
2005
776
0.150
 Why?
Estrogen Receptor alpha
2
2018
126
0.150
 Why?
Triazoles
1
2018
134
0.150
 Why?
Caspase 3
3
2006
243
0.140
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
229
0.140
 Why?
Smad Proteins
1
2016
39
0.140
 Why?
Gene Knock-In Techniques
1
2016
47
0.140
 Why?
Calcitriol
1
2016
55
0.140
 Why?
Ovary
1
2017
205
0.140
 Why?
Estrogens
1
2018
328
0.130
 Why?
Proteins
2
1992
938
0.130
 Why?
Drug Screening Assays, Antitumor
2
2016
189
0.130
 Why?
Protein Tyrosine Phosphatases
1
2016
145
0.130
 Why?
Gene Amplification
2
2009
97
0.130
 Why?
Fatty Acid Synthase, Type I
1
2014
5
0.130
 Why?
Mental Disorders
1
2023
939
0.130
 Why?
Immunoradiometric Assay
1
1994
2
0.120
 Why?
Cathepsin D
1
1994
13
0.120
 Why?
Postpartum Period
2
2014
271
0.120
 Why?
Disease Progression
6
2018
2490
0.120
 Why?
Antibodies, Monoclonal, Humanized
4
2013
667
0.120
 Why?
Immunoprecipitation
2
2011
161
0.120
 Why?
Mice, Knockout
1
2020
2680
0.120
 Why?
Androgen Receptor Antagonists
1
2014
32
0.120
 Why?
Tumor Cells, Cultured
5
2009
874
0.120
 Why?
Insulin-Like Growth Factor I
1
2016
287
0.120
 Why?
Adenocarcinoma
3
2012
812
0.120
 Why?
Androgen Antagonists
1
2014
70
0.110
 Why?
Receptor, ErbB-4
2
2010
19
0.110
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
69
0.110
 Why?
Transforming Growth Factor beta
1
2016
462
0.110
 Why?
Vitamin D
1
2016
354
0.110
 Why?
Nucleic Acid Hybridization
2
2003
193
0.110
 Why?
Blotting, Western
3
2011
1194
0.110
 Why?
Overnutrition
1
2012
39
0.110
 Why?
Disease Models, Animal
4
2017
3730
0.110
 Why?
Aminosalicylic Acids
1
2012
7
0.110
 Why?
DNA, Neoplasm
6
2005
154
0.110
 Why?
Benzenesulfonates
1
2012
23
0.110
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
226
0.100
 Why?
RNA, Messenger
4
2016
2657
0.100
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
58
0.100
 Why?
Gene Expression Profiling
2
2016
1597
0.100
 Why?
Chromones
1
2011
37
0.100
 Why?
Genital Diseases, Female
1
1991
28
0.100
 Why?
Dasatinib
1
2011
46
0.100
 Why?
Fluoxymesterone
1
1991
2
0.100
 Why?
Proportional Hazards Models
4
2005
1125
0.100
 Why?
Mitosis
3
2001
172
0.100
 Why?
Cohort Studies
2
2020
5116
0.100
 Why?
S Phase
2
2010
74
0.100
 Why?
Thiazoles
1
2011
121
0.100
 Why?
Apoptosis Regulatory Proteins
1
2012
190
0.100
 Why?
Reagent Kits, Diagnostic
1
1991
42
0.100
 Why?
Morpholines
1
2011
106
0.100
 Why?
Weight Gain
3
2022
493
0.100
 Why?
Genital Neoplasms, Female
1
1991
72
0.090
 Why?
Neoplasm Metastasis
5
2005
544
0.090
 Why?
Chromosomes, Human, Pair 17
3
2002
63
0.090
 Why?
Proto-Oncogenes
1
1989
27
0.090
 Why?
Flow Cytometry
3
2007
1085
0.090
 Why?
Antibiotics, Antineoplastic
2
2009
114
0.090
 Why?
Radioisotopes
1
1989
34
0.090
 Why?
Aged
12
2015
19657
0.090
 Why?
Dose-Response Relationship, Drug
2
2008
1945
0.090
 Why?
Adult
15
2021
31512
0.090
 Why?
Anthracyclines
1
2009
41
0.090
 Why?
DNA Topoisomerases, Type II
1
2009
45
0.090
 Why?
Treatment Outcome
5
2007
9342
0.080
 Why?
Pyrimidines
1
2011
382
0.080
 Why?
DNA-Binding Proteins
2
2009
1346
0.080
 Why?
Epithelial Cells
1
2014
963
0.080
 Why?
Gene Deletion
2
2002
361
0.080
 Why?
MAP Kinase Signaling System
1
2010
292
0.080
 Why?
AMP-Activated Protein Kinases
1
2009
178
0.080
 Why?
Mutation
3
1995
3457
0.080
 Why?
RNA, Small Interfering
2
2007
564
0.080
 Why?
Gene Dosage
1
2008
136
0.080
 Why?
Mice, Nude
1
2009
663
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
982
0.080
 Why?
Energy Metabolism
1
2012
767
0.080
 Why?
Immunoenzyme Techniques
3
1999
195
0.070
 Why?
Transcription Factors
2
2008
1570
0.070
 Why?
Protein Structure, Tertiary
1
2009
823
0.070
 Why?
Time Factors
4
2015
6412
0.070
 Why?
Proto-Oncogene Proteins c-akt
3
2016
420
0.070
 Why?
Enzyme Precursors
1
2006
15
0.070
 Why?
Mitochondria
3
2008
786
0.070
 Why?
Epigenesis, Genetic
1
2010
539
0.070
 Why?
Receptor, Notch1
1
2006
65
0.070
 Why?
Lamin Type B
1
2005
5
0.070
 Why?
Multigene Family
2
2003
200
0.070
 Why?
Herpes Simplex
1
2006
90
0.070
 Why?
Herpesvirus 1, Human
1
2006
81
0.070
 Why?
Age Factors
3
2003
2995
0.070
 Why?
Cell Nucleolus
1
2005
17
0.070
 Why?
Tumor Microenvironment
2
2018
454
0.070
 Why?
Nitriles
2
2017
155
0.060
 Why?
Benzamides
2
2017
176
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
109
0.060
 Why?
Follow-Up Studies
4
2007
4596
0.060
 Why?
Aged, 80 and over
4
2000
6561
0.060
 Why?
Feedback
1
2005
153
0.060
 Why?
RNA Interference
3
2015
460
0.060
 Why?
Tacrolimus Binding Protein 1A
1
2003
7
0.060
 Why?
Tacrolimus Binding Proteins
1
2003
17
0.060
 Why?
Predictive Value of Tests
4
2011
1868
0.060
 Why?
Protein Kinases
1
2006
310
0.060
 Why?
Rats, Wistar
2
2017
399
0.060
 Why?
Adipose Tissue
2
2018
606
0.060
 Why?
Estrogens, Non-Steroidal
1
2003
5
0.060
 Why?
Genes, Tumor Suppressor
1
2003
77
0.060
 Why?
Mice, Inbred Strains
1
2004
405
0.060
 Why?
Phytoestrogens
1
2003
17
0.060
 Why?
Plant Preparations
1
2003
23
0.060
 Why?
Estrogen Antagonists
1
2003
39
0.060
 Why?
Lymph Node Excision
2
2021
158
0.060
 Why?
Actins
1
2005
404
0.060
 Why?
Cell Line
2
2003
2707
0.060
 Why?
Chromosome Banding
1
2002
18
0.050
 Why?
Anticarcinogenic Agents
1
2003
68
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
30
0.050
 Why?
Mammary Glands, Animal
1
2003
124
0.050
 Why?
Rodentia
1
2022
47
0.050
 Why?
3' Untranslated Regions
2
2014
142
0.050
 Why?
Transfection
3
2015
888
0.050
 Why?
Trefoil Factor-1
2
1992
2
0.050
 Why?
Nuclear Proteins
2
2000
597
0.050
 Why?
alpha-Fetoproteins
1
2021
33
0.050
 Why?
Fallopian Tubes
2
1991
28
0.050
 Why?
In Situ Nick-End Labeling
1
2001
124
0.050
 Why?
Chorionic Gonadotropin
1
2021
80
0.050
 Why?
Sweden
1
2021
63
0.050
 Why?
RNA, Catalytic
1
2002
182
0.050
 Why?
Plasmids
1
2002
355
0.050
 Why?
Neoplasm, Residual
1
2021
103
0.050
 Why?
RNA Stability
1
2021
97
0.050
 Why?
Antigens, Nuclear
1
2000
18
0.050
 Why?
Breast Diseases
1
2000
20
0.050
 Why?
Enhancer Elements, Genetic
1
2000
152
0.040
 Why?
Reproducibility of Results
2
2021
2874
0.040
 Why?
Integrin beta3
2
2013
9
0.040
 Why?
Telomerase
1
2001
207
0.040
 Why?
Tumor Suppressor Proteins
2
1992
289
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
5
0.040
 Why?
DNA Glycosylases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
6
0.040
 Why?
Loss of Function Mutation
1
2018
42
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
40
0.040
 Why?
Case-Control Studies
2
2023
3171
0.040
 Why?
Antibodies
1
2000
392
0.040
 Why?
Trans-Activators
1
2000
373
0.040
 Why?
Codon
3
1993
89
0.040
 Why?
Half-Life
1
2018
147
0.040
 Why?
Stromal Cells
1
2018
102
0.040
 Why?
NF-kappa B
1
2002
670
0.040
 Why?
Retrospective Studies
4
2005
12978
0.040
 Why?
Hyaluronan Receptors
1
1998
93
0.040
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
175
0.040
 Why?
Organic Cation Transporter 2
1
2017
8
0.040
 Why?
Gene Expression
3
2013
1489
0.040
 Why?
Extracellular Matrix Proteins
1
1998
133
0.040
 Why?
Antigens, CD
2
2014
460
0.040
 Why?
DNA Repair
1
1998
198
0.040
 Why?
Steroids
1
2017
153
0.040
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
12
0.030
 Why?
Oncogenes
1
2016
111
0.030
 Why?
Chromatography, Liquid
1
2017
355
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
27
0.030
 Why?
Survival Rate
3
1998
1720
0.030
 Why?
Oncogene Proteins
1
1995
52
0.030
 Why?
RNA
1
2001
833
0.030
 Why?
Cell Nucleus
3
2006
580
0.030
 Why?
Homeodomain Proteins
1
2018
468
0.030
 Why?
Analysis of Variance
2
2014
1293
0.030
 Why?
Tosyl Compounds
1
2014
14
0.030
 Why?
Mammary Glands, Human
1
2014
61
0.030
 Why?
Integrin alpha6
1
2013
6
0.030
 Why?
Leukocyte Common Antigens
1
2014
76
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
55
0.030
 Why?
Mass Spectrometry
1
2017
681
0.030
 Why?
Parity
1
2014
101
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
290
0.030
 Why?
Testosterone
1
2017
351
0.030
 Why?
Sirolimus
2
2006
195
0.030
 Why?
Premenopause
1
2014
108
0.030
 Why?
Immunoassay
1
1994
101
0.030
 Why?
Anilides
1
2014
69
0.030
 Why?
Brain Neoplasms
2
1993
1022
0.030
 Why?
Neoplasms
2
2012
2179
0.030
 Why?
Transplantation, Heterologous
1
2014
194
0.030
 Why?
Neoplasm Transplantation
1
2014
245
0.030
 Why?
Neovascularization, Pathologic
1
1995
287
0.030
 Why?
Interleukin-6
1
2017
688
0.030
 Why?
bcl-2-Associated X Protein
2
2007
46
0.030
 Why?
Organ Specificity
1
2013
278
0.030
 Why?
Lactation
1
2014
160
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2013
44
0.030
 Why?
Young Adult
2
2021
10793
0.030
 Why?
Immune System
1
2014
181
0.030
 Why?
Lipogenesis
1
2012
66
0.030
 Why?
Point Mutation
1
1993
228
0.030
 Why?
Molecular Targeted Therapy
1
2015
356
0.030
 Why?
Astrocytoma
1
1993
113
0.030
 Why?
Broad Ligament
1
1991
2
0.030
 Why?
Gene Knockdown Techniques
1
2013
311
0.030
 Why?
Peritoneum
1
1991
36
0.030
 Why?
Tumor Necrosis Factor-alpha
2
2007
1171
0.030
 Why?
Glycolysis
1
2012
224
0.030
 Why?
Mucins
1
1991
59
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
51
0.020
 Why?
Pilot Projects
1
2015
1419
0.020
 Why?
Blotting, Northern
1
2010
194
0.020
 Why?
Evaluation Studies as Topic
1
1991
182
0.020
 Why?
Hormones
1
1991
135
0.020
 Why?
Pregnancy
2
2014
5691
0.020
 Why?
Soft Tissue Neoplasms
1
1991
93
0.020
 Why?
In Situ Hybridization
1
2010
311
0.020
 Why?
Glioblastoma
1
1993
262
0.020
 Why?
Precipitin Tests
1
1989
93
0.020
 Why?
Cells, Cultured
2
2013
4077
0.020
 Why?
Prospective Studies
1
2021
6471
0.020
 Why?
Radionuclide Imaging
1
1989
124
0.020
 Why?
Risk Factors
1
2003
9000
0.020
 Why?
Odds Ratio
1
1992
996
0.020
 Why?
Protein Multimerization
1
2010
161
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
770
0.020
 Why?
Lymph Nodes
1
1991
455
0.020
 Why?
Drug Interactions
1
2009
352
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
56
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Cytochromes c
1
2007
64
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Male
3
2023
57801
0.020
 Why?
Caspase 2
1
2006
14
0.020
 Why?
Caspase 8
1
2006
47
0.020
 Why?
Caspase 9
1
2006
50
0.020
 Why?
Aging
2
2002
1670
0.020
 Why?
Biomarkers
1
2017
3588
0.020
 Why?
Cysteine Endopeptidases
1
2006
61
0.020
 Why?
Amino Acid Sequence
3
1998
2071
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
13
0.020
 Why?
Caspase 7
1
2006
23
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
27
0.020
 Why?
Vero Cells
1
2006
69
0.020
 Why?
Antineoplastic Agents, Phytogenic
1
2007
180
0.020
 Why?
Isoenzymes
1
2007
297
0.020
 Why?
Cytosol
1
2006
221
0.020
 Why?
Promoter Regions, Genetic
1
2010
1158
0.020
 Why?
Virus Assembly
1
2006
67
0.020
 Why?
Base Sequence
2
2003
2159
0.020
 Why?
Adolescent
2
2021
18480
0.020
 Why?
Protein Binding
1
2010
1975
0.020
 Why?
Taxoids
1
2004
98
0.010
 Why?
Protein Processing, Post-Translational
1
2006
408
0.010
 Why?
DNA, Complementary
1
2003
268
0.010
 Why?
Mice, Inbred C57BL
2
2003
4908
0.010
 Why?
Melanoma, Experimental
1
2003
118
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
43
0.010
 Why?
Exons
2
1993
307
0.010
 Why?
Cell Adhesion
1
2003
443
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
55
0.010
 Why?
Gene Targeting
1
2002
80
0.010
 Why?
Templates, Genetic
1
2001
59
0.010
 Why?
Substrate Specificity
1
2002
371
0.010
 Why?
DNA, Superhelical
1
2000
11
0.010
 Why?
DNA Footprinting
1
2000
28
0.010
 Why?
Molecular Sequence Data
2
1998
2871
0.010
 Why?
Proto-Oncogene Proteins c-ets
1
2000
51
0.010
 Why?
Mice, Inbred BALB C
1
2003
1206
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
18
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
103
0.010
 Why?
Macromolecular Substances
1
2000
201
0.010
 Why?
Pathology, Clinical
1
2000
31
0.010
 Why?
Gene Silencing
1
2000
177
0.010
 Why?
Multicenter Studies as Topic
1
2000
253
0.010
 Why?
Genetic Therapy
1
2000
267
0.010
 Why?
Forecasting
1
2000
353
0.010
 Why?
Receptors, Cell Surface
1
2000
367
0.010
 Why?
Binding Sites
1
2000
1224
0.010
 Why?
Nucleic Acid Conformation
1
2000
670
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
18
0.010
 Why?
ras Proteins
1
1998
141
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
51
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
66
0.010
 Why?
Adenine
1
1998
223
0.010
 Why?
Immunoblotting
1
1997
307
0.010
 Why?
Societies, Medical
1
2000
703
0.010
 Why?
Hyaluronic Acid
1
1998
197
0.010
 Why?
Heterozygote
1
1996
262
0.010
 Why?
United States
2
2004
12555
0.010
 Why?
Protein Isoforms
1
1997
345
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
30
0.010
 Why?
Factor VIII
1
1995
56
0.010
 Why?
Melanoma
1
2002
664
0.010
 Why?
Cyclin D1
1
1995
61
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1244
0.010
 Why?
Single-Blind Method
1
1995
269
0.010
 Why?
Transcription, Genetic
1
2000
1323
0.010
 Why?
Observer Variation
1
1995
309
0.010
 Why?
Alleles
1
1996
832
0.010
 Why?
Biopsy
1
1995
1079
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
55
0.010
 Why?
Peripheral Nerves
1
1991
65
0.010
 Why?
Risk Assessment
1
2000
3057
0.010
 Why?
Protein Conformation
1
1993
848
0.010
 Why?
DNA
1
1996
1388
0.010
 Why?
Polymorphism, Genetic
1
1993
642
0.010
 Why?
Lung Neoplasms
1
2002
2220
0.010
 Why?
Cerebral Cortex
1
1991
416
0.000
 Why?
Glioma
1
1991
306
0.000
 Why?
Child
1
1993
19129
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (434) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)